
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2024 Earnings Call Transcript
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2024 Earnings Call Transcript March 27, 2025 Plus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.51. Operator: Good afternoon, ladies and gentlemen. Welcome to …